Browse the evidence

Obesity without metabolic syndrome ('metabolically healthy obesity') significantly increases the 5-year cumulative incidence of hypertension and diabetes compared to lean subjects without metabolic syndrome.

If you are overweight or obese, even if your current blood pressure and blood sugar are normal, you are at a significantly higher risk of developing hypertension and diabetes within five years compared to someone of normal weight. You should not assume 'normal labs' mean 'no risk.'

Hyperuricemia is an independent risk factor for developing hypertension and diabetes, with every 1 mg/dL increase in serum uric acid increasing the risk of hypertension by 19% and diabetes by 27%.

High uric acid is not just about gout; it independently raises your risk of high blood pressure and diabetes. If your uric acid is high, addressing it (often through diet, specifically reducing fructose and purines) may help prevent these conditions.

Among patients with type 2 diabetes, a BMI of 30–34.9 kg/m² is associated with the lowest all-cause mortality risk, while risks significantly increase at BMIs <30 kg/m² (for blacks) or <25 kg/m² (for whites) and ≥35 kg/m² (for blacks) or ≥40 kg/m² (for whites).

If you have Type 2 Diabetes, current large-scale data suggests that maintaining a BMI between 30 and 35 kg/m² is associated with the lowest risk of death compared to being underweight or morbidly obese. While standard guidelines often target a BMI <25, this study indicates that aggressively lowering your BMI below 30 (for Black patients) or 25 (for White patients) might actually increase your mortality risk. Do not attempt rapid weight loss to reach 'normal' BMI ranges without discussing these specific mortality risks with your endocrinologist, as your current weight may be providing a metabolic buffer.

Sibutramine (10-30 mg/day) produces significant weight loss in overweight women primarily through appetite suppression (anorectic effect) rather than by increasing Resting Metabolic Rate (RMR).

Sibutramine is an effective weight-loss drug for overweight women, but it works by reducing appetite, not by speeding up your metabolism. Expect to lose about 7-8% of body weight over 8 weeks when combined with a controlled diet (1200 kcal/day). Do not rely on it to increase your resting energy expenditure.

Carriers of the minor G allele of the MTIF3 rs1885988 variant experience significantly greater weight loss from intensive lifestyle interventions compared to non-carriers, despite this allele being associated with higher baseline BMI.

If you have a family history of obesity, do not assume lifestyle changes are futile. Research suggests that specific genetic markers associated with higher body weight may actually predict a stronger positive response to intensive lifestyle interventions (diet and exercise). Your genetic risk profile might mean you lose more weight than expected when you commit to lifestyle changes, so focus on consistent adherence to diet and physical activity goals.

GLP-1 receptor agonists improve cardiovascular risk factors (blood pressure, lipid profiles, endothelial function) and reduce cardiovascular events in patients with type 2 diabetes and obesity.

GLP-1 injections not only help with weight and blood sugar but also improve heart health by lowering blood pressure, improving cholesterol, and reducing inflammation. They are recommended for patients with T2DM and obesity to reduce cardiovascular risk.

Resistance exercise decreases the phosphorylation of eIF2Bε, a mechanism that potentiates the feeding-induced stimulation of p70S6K1 and rpS6, thereby enhancing muscle protein synthesis signaling in young men.

To maximize muscle growth, you must combine resistance training with adequate nutrition. This study shows that exercise changes how your muscles respond to food by deactivating inhibitory signals (eIF2Bε phosphorylation). Without the exercise stimulus, feeding alone does not trigger the same level of anabolic signaling (p70S6K1 and rpS6) as the combination of both.

Statins are safe and effective as first-line treatment for hyperlipidemia in MASLD patients, despite under-prescription, and may reduce cardiovascular events and liver disease burden.

If you have MASLD and high cholesterol or CVD risk, ask your doctor about statins. They are safe for your liver, even if you have some liver scarring, and are the first-line treatment to lower your risk of heart disease. Do not avoid them due to fear of liver damage.

Higher overall diet quality, measured by the modified Alternative Healthy Eating Index (mAHEI), is associated with a significantly reduced risk of cognitive decline in high-risk cardiovascular patients.

Adopt a diet high in vegetables, fruits, whole grains, nuts, and soy, while limiting deep-fried foods and red meat. This pattern, measured by the modified Alternative Healthy Eating Index, is associated with a 24% lower risk of cognitive decline in high-risk individuals. Focus on consistent, long-term adherence to these core food groups rather than short-term restrictive diets.

Tirzepatide treatment significantly reduces the 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) in adults with obesity or overweight without diabetes compared to placebo.

If you have obesity or overweight without diabetes, treatment with tirzepatide (a once-weekly injection) combined with lifestyle changes can significantly lower your calculated 10-year risk of heart disease compared to placebo. This benefit was observed across different baseline risk levels, suggesting it may be a valuable option for long-term cardiovascular health improvement in this population.

Preventing adult obesity requires population-level 'small changes' in energy balance (approx. 100 kcal/day reduction in intake and 100 kcal/day increase in expenditure) initiated in childhood, rather than relying on large-scale individual weight loss interventions.

To prevent weight gain, you don't need to overhaul your life. Focus on small, sustainable shifts: walk an extra 2,000 steps a day (use a pedometer) and cut out one high-calorie item from your diet (like a sugary drink or a small snack) each day. Start these habits early in life, as they are easier to maintain than drastic weight loss programs.

Reducing dietary fat intake to lower levels spontaneously reduces daily energy consumption by approximately 270 kcal, effectively resetting energy balance and preventing significant weight gain.

You can reduce your calorie intake without counting calories by choosing foods with lower fat content. This often leads to eating less naturally. For example, swapping high-fat snacks for lower-fat alternatives can save you hundreds of calories a day without feeling deprived.

Variable-intensity (VI) cycling, when matched for average power output to steady-state (SS) cycling, results in significantly greater plasma glucose oxidation and reduced muscle glycogen utilization, yet yields equivalent subsequent time-trial performance.

If you are a trained cyclist, switching from steady-state to variable-intensity training (matching the same average power) will change how your body uses fuel (more blood glucose, less muscle glycogen). However, this metabolic shift does not translate to faster race times or time-trial performance. You do not need to use variable intensity solely to 'save glycogen' if your goal is faster performance at a specific average power; steady-state may be equally effective and potentially simpler to execute.

Intermittent fasting (including 16:8 and 5:2 protocols) produces weight loss equivalent to continuous energy restriction when total caloric intake is matched.

Intermittent fasting (like 16:8 or 5:2) is an effective weight loss strategy, but only because it helps you eat fewer calories. It is not superior to eating fewer calories every day. Choose the pattern that best fits your lifestyle and helps you maintain a caloric deficit.

Certain diabetes medications (GLP-1 agonists and SGLT2 inhibitors) promote weight loss, whereas others (insulin, sulphonylureas, thiazolidinediones) cause weight gain, influencing the choice of therapy in obese patients.

When choosing diabetes medication, ask your doctor about its effect on your weight. Some drugs (like GLP-1 agonists and SGLT2 inhibitors) help you lose weight, while others (like insulin and sulphonylureas) may cause weight gain. If you have obesity, your doctor should prioritize medications that support weight loss.

SGLT-2 inhibitors reduce body weight (0.9-2.5 kg) and improve cardiovascular and renal outcomes in patients with diabesity by inducing glycosuria, making them a valuable class of medication for managing both metabolic and organ-specific risks.

SGLT-2 inhibitors (like Jardiance or Farxiga) are oral diabetes medications that also help with modest weight loss (1-2.5 kg) and protect your heart and kidneys. They work by removing excess sugar through urine. While this can increase the risk of yeast infections or UTIs, good hygiene and doctor guidance can manage this. They are particularly beneficial if you have heart or kidney risks associated with your diabetes.

Regular aerobic exercise attenuates the metabolic drive to regain weight after long-term weight loss by reducing the energy gap between appetite and expenditure and blunting the shift in fuel utilization that favors rapid weight regain.

If you have lost weight, simply maintaining a lower calorie intake is often not enough to prevent regain because your body biologically fights back by increasing hunger and efficiency. Regular aerobic exercise (like brisk walking or jogging) helps counteract these biological changes by reducing the drive to overeat and improving how your body uses fuel, thereby helping you maintain your new weight more easily.

Higher dietary glycemic load (GL) is associated with a significantly increased risk of coronary heart disease (CHD), with a relative risk of 1.44 per 65 g/d increase in GL among populations using valid dietary instruments.

To lower your risk of heart disease, pay attention to the glycemic load of your diet. This means choosing carbohydrates that have less impact on your blood sugar. The study suggests that for every 65 grams of glycemic load you consume daily, your risk of coronary heart disease increases by about 44% compared to lower intake, assuming you use accurate dietary tracking. Prioritize low-GL foods like vegetables, legumes, and whole grains over high-GL refined carbs.

Higher dietary glycemic index (GI) is associated with an increased risk of coronary heart disease, with a relative risk of 1.24 per 10 unit increase in GI on the glucose scale.

Choose carbohydrates with a lower Glycemic Index (GI) to support heart health. The study indicates that for every 10-unit increase in GI, your risk of coronary heart disease increases by about 24%. This means prioritizing foods that digest slowly and cause a smaller spike in blood sugar, such as legumes, whole grains, and non-starchy vegetables, over refined grains and sugary foods.

The risk of coronary heart disease from carbohydrate intake is significantly dependent on the Glycemic Index (GI) of the carbohydrates consumed, with higher GI amplifying the risk.

When consuming carbohydrates, their quality (Glycemic Index) significantly impacts your heart disease risk. The study shows that for every 98 grams of carbohydrates consumed, the risk of CHD increases by 66% for every 10-unit increase in the GI of those carbs. To protect your heart, choose carbohydrates with a lower GI, such as whole grains, legumes, and vegetables, and limit high-GI refined carbohydrates.

Intensive lifestyle intervention (ILI) aimed at weight loss reduces the incidence of obesity-related cancers by 16% in adults with type 2 diabetes, although the result was not statistically significant due to insufficient statistical power.

For individuals with type 2 diabetes and obesity, engaging in a structured weight loss program involving calorie restriction (1,200-1,800 kcal/day), moderate exercise (175 mins/week), and behavioral counseling can significantly lower the risk of developing obesity-related cancers. While the statistical evidence in this specific trial was borderline due to sample size, the consistent trend toward reduced risk suggests that maintaining a healthy weight is a critical cancer prevention strategy for this population.

Higher circulating levels of docosahexaenoic acid (DHA) are inversely associated with the risk of incident atherothrombotic stroke, while higher levels of docosapentaenoic acid (DPA) are inversely associated with cardioembolic stroke.

If you are concerned about stroke risk, maintaining healthy levels of specific omega-3 fatty acids like DHA and DPA may be beneficial. DHA appears to help prevent strokes caused by atherosclerosis (plaque buildup), while DPA may help prevent strokes caused by heart rhythm issues like atrial fibrillation. Since EPA did not show a significant association in this study, focusing on a balanced intake of all long-chain omega-3s through diet (fatty fish) or high-quality supplements is advisable, rather than relying on a single type.

Higher daily physical activity in nonagenarians (90+ years) is positively associated with better physical functionality, specifically the ability to walk further in a timed test.

For those in their 90s, staying active is directly linked to maintaining the ability to move independently. Even small increases in daily activity (Physical Activity Level) correlate with walking further and having better physical functionality. Prioritize daily movement to preserve mobility.

Adherence to a Mediterranean diet increases circulating levels of specific endothelial progenitor cell (EPC) phenotypes (CD34+KDR+ and CD34+KDR+CD133+) and promotes the regression of carotid intima-media thickness (CIMT) in patients with newly diagnosed type 2 diabetes.

For individuals with newly diagnosed type 2 diabetes, adopting a Mediterranean-style diet—characterized by high intake of vegetables, whole grains, and olive oil, with moderate protein from poultry and fish and low red meat—can significantly improve blood vessel health. This dietary pattern increases the body's supply of endothelial progenitor cells (which repair blood vessels) and helps reverse early signs of atherosclerosis (thickening of artery walls) more effectively than a standard low-fat diet. This benefit is sustained over the long term (5+ years).